Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |